Dr. Mireya A. Wessolossky, MD

Dr. Wessolossky practices at Umass Memorial Medical Center in Mendon, Massachusetts.

Dr. Wessolossky's NPI, 1083604474, was assigned on October 26, 2005. Dr. Wessolossky holds Massachusetts license 153768.

Dr. Wessolossky's primary practice is Umass Memorial Medical Center, at 55 North Ave, Mendon, MA 01756 in Worcester County. The practice phone is (508) 334-1000.

Dr. Wessolossky's primary practice is Umass Memorial Medical Center in Mendon, Massachusetts. Dr. Wessolossky is also affiliated with UMass Memorial Medical Center - University Campus. The medical group on file is UMass Memorial Medical Group. Dmand AI also links Dr. Wessolossky to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wessolossky practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Wessolossky's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Wessolossky is licensed in Massachusetts.

CMS data shows 284 Medicare services from Dr. Wessolossky across 4 procedure codes in 2024, for 219 Medicare patients. Medicare paid $24,991 for them.

CMS counts 219 Medicare patients who saw Dr. Wessolossky in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 60% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wessolossky's median patient age at 67, with 35% women.

In 2024, Dr. Wessolossky wrote 1,251 Medicare Part D claims for 102 patients. 39% of them were for generic drugs. CMS names the drug for 1,035 of them, across 34 drugs with 11 or more claims each, at $2,353,164 in total drug cost. In 2023, CMS named 1,179 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Wessolossky for performance year 2024, reported through an alternative payment model (APM). Dr. Wessolossky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wessolossky as offering telehealth.

Dmand AI links 6 papers to Dr. Wessolossky, published from 2013 to 2024. The most frequent topics are COVID-19 and SARS-CoV-2. Dr. Wessolossky's most frequent co-authors are Suzanne Donovan, MD, Samuel Clay Fountain, MD and Sumanth Gandra, MD.

CMS Open Payments shows 43 general payments to Dr. Wessolossky from 5 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 72% of the total. Gilead Sciences, Inc. paid the most, $16,001.